Swiss Biotechs May Get SPAC Listing Option Soon
SPACs could ‘jump start’ Switzerland’s stalled IPO market
Although 2020 was the best year ever for Swiss biotech financing activities, no domestic IPOs were launched by the sector. But introducing the SPAC might change that.
